OutSee

OutSee is a London-based genomics and AI company developing a novel predictive platform called Nomaly. Unlike traditional genomics tools that rely on pattern-matching known genetic associations, Nomaly aims to predict disease and traits directly from a single genome by modeling underlying molecular and cellular biology. This approach allows the company to work effectively with smaller patient cohorts and complex genetic interactions, targeting applications in precision medicine and therapeutic target discovery. OutSee is a private, likely pre-revenue platform company seeking to address the innovation gap between sequencing technology and genomic analysis.

Nomaly, a predictive AI engine that models disease and phenotype directly from a single genome using fundamental molecular and cell biology principles, rather than relying on pattern-matching known genetic associations.

OutSee competes in a crowded field of AI/ML genomics companies, but differentiates by claiming a first-principles, biology-driven approach versus the dominant correlation-based methods. It must contend with well-funded players like Tempus, Sophia Genetics, and numerous AI-native drug discovery firms.